ReviewIndian journal of dermatology
Psychotropic Drugs in Dermatology. Part 2: Antipsychotics, Sedative-Hypnotics and Anxiolytics in Dermatology.
Review in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatology as a branch is a panoramic canvas with a spectrum of manifestation, and psychodermatology is one emerging paradigm in its epicentre. Traditionally, it was thought that psychiatrists deal with "internal" nonvisible disease, while dermatology centres around "external" visible dermatoses and cosmetic disfigurement, hence, with this belief, psychodermatology appeared as an oxymoron to many. Management of psychodermatological disorders requires a multidisciplinary approach, which includes a combination of psychopharmacology, psychotherapy and timely referral as and when needed. The commonly available psychotherapeutics at the disposal of dermatologists include antidepressants, mood stabilizers, antipsychotics, anxiolytics and sedative-hypnotics, the last three of which have been focused in this part of the review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.